GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Navamedic ASA (FRA:N1A) » Definitions » Price-to-Owner-Earnings

Navamedic ASA (FRA:N1A) Price-to-Owner-Earnings : (As of May. 21, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Navamedic ASA Price-to-Owner-Earnings?

As of today (2024-05-21), Navamedic ASA's share price is €2.83. Navamedic ASA does not have enough data to calculate Owner Earnings per Share (TTM), so as pPrice-to-Owner-Earnings.


The historical rank and industry rank for Navamedic ASA's Price-to-Owner-Earnings or its related term are showing as below:

During the past 13 years, the highest Price-to-Owner-Earnings of Navamedic ASA was 45.94. The lowest was 1.63. And the median was 4.08.


FRA:N1A's Price-to-Owner-Earnings is not ranked *
in the Medical Distribution industry.
Industry Median: 13.67
* Ranked among companies with meaningful Price-to-Owner-Earnings only.

As of today (2024-05-21), Navamedic ASA's share price is €2.83. Navamedic ASA's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €0.02. Therefore, Navamedic ASA's PE Ratio for today is 176.88.

As of today (2024-05-21), Navamedic ASA's share price is €2.83. Navamedic ASA's EPS without NRI for the trailing twelve months (TTM) ended in was €0.11. Therefore, Navamedic ASA's PE Ratio without NRI for today is 25.50.

During the past 13 years, Navamedic ASA's highest PE Ratio without NRI was 955.26. The lowest was 15.54. And the median was 31.13.


Navamedic ASA Price-to-Owner-Earnings Historical Data

The historical data trend for Navamedic ASA's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Navamedic ASA Price-to-Owner-Earnings Chart

Navamedic ASA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.54 - - 40.50 -

Navamedic ASA Semi-Annual Data
Jun14 Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 40.50 - -

Competitive Comparison of Navamedic ASA's Price-to-Owner-Earnings

For the Medical Distribution subindustry, Navamedic ASA's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Navamedic ASA's Price-to-Owner-Earnings Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, Navamedic ASA's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Navamedic ASA's Price-to-Owner-Earnings falls into.



Navamedic ASA Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Navamedic ASA's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=2.83/-0.07
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Navamedic ASA  (FRA:N1A) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Navamedic ASA Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Navamedic ASA's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Navamedic ASA (FRA:N1A) Business Description

Traded in Other Exchanges
Address
Henrik Ibsensgate 100, Solli Plass, Lysaker, NOR, N-0255
Navamedic ASA is a pharmaceutical company that operates in a single segment, which is marketing, selling, and distributing pharmaceuticals and medical nutrition products to hospitals, pharmacies, and patients, bought from product suppliers and manufacturers in Europe and other places. Its product categories include Medical nutrition, Consumer health, Branded generics, and Specialty pharma.

Navamedic ASA (FRA:N1A) Headlines

No Headlines